by Ken Alltucker – Feb. 23, 2012 05:41 PM
The Republic | azcentral.com
Scottsdale Healthcare has bolstered its cancer-care offerings with a new bone-marrow transplant program that will serve patients receiving treatment for aggressive blood cancers.
The new program at the Virginia G. Piper Cancer Center at Scottsdale Shea Medical Center will cater to patients who are battling blood cancers such as myeloma, leukemia and lymphoma.
The program is staffed by two physicians who are bone-marrow transplant specialists and a team of nearly 40 support staff, including nurses, care coordinators, social workers, administrators and others.
Scottsdale Healthcare’s new program largely includes practitioners who previously staffed a bone-marrow transplant program at Banner Good Samaritan Medical Center in Phoenix.
The physicians and some support staff left when Banner Health sought to relocate the program to the new Banner MD Anderson Cancer Center, which opened last fall in Gilbert.
Drs. Jeffrey Schriber and Adrienne Briggs, both bone-marrow transplant specialists, established the Cancer Transplant Institute at Virginia G. Piper Cancer Center because they viewed it as a better fit for their team.
“Much of our team is part of the previous Banner Health team,” Schriber said. “For a variety of reasons, it didn’t end up working there.”
Mayo Clinic operates the other major bone-marrow transplant program in metro Phoenix. Mayo’s program has 10 physicians and treated 200 adults and 21 children last year, more than doubling its transplant cases since 2008, according to figures provided by Mayo Clinic.
Banner MD Anderson Cancer Center also is recruiting physicians and support staff for a bone-marrow transplant program, but the Gilbert cancer center has not established an expected launch date for the program, a spokeswoman said.
Chemotherapy treatment targeting cancerous tumors can damage a person’s bone marrow, resulting in low blood counts and weakened immune systems. The bone marrow can come from donors or from the patient’s own stem cells collected before the patient undergoes chemotherapy. The patient gets the transplants to counteract the side effects from chemotherapy, particularly in blood cancers that require high chemotherapy doses to target aggressive tumors.
The new Scottsdale Healthcare program opened in November. Physicians have seen about 50 patients and recently performed their first transplant at the new program.
The program includes an outpatient center within the Virginia G. Piper Cancer Center at 10460 N. 92nd St. It also has a 13-bed inpatient unit with a specialized air system designed to protect patients when they are vulnerable to infection.
Schriber said the program has been accredited by the Foundation for the Accreditation of Cellular Therapy, a designation that health insurers require before allowing payment.
Posted by S. Lewis 